Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
<p>Abstract</p> <p>Introduction</p> <p>We have shown that the radio sensitizer DCQ enhances sensitivity of HCT116 human colon cancer cells to hypoxia. However, it is not known whether the p53 or p21 genes influence cellular response to DCQ. In this study, we used HCT116...
Main Authors: | Haddadin Makhluf J, Geara Fady, El-Khatib Mona, Gali-Muhtasib Hala |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | Radiation Oncology |
Online Access: | http://www.ro-journal.com/content/5/1/107 |
Similar Items
-
Radiosensitization by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide under oxia and hypoxia in human colon cancer cells
by: Haddadin Makhluf, et al.
Published: (2007-01-01) -
The radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells
by: Smith Colin A, et al.
Published: (2009-07-01) -
Novel 2‑(5-Imino‑5H‑isoquinolones[3,4‑b]quinoxalin-7-ylmethyl)-benzonitrile (DIQ3) and Other Related Derivatives Targeting Colon Cancer Cells: Syntheses and in Vitro Models
by: Alissar Monzer, et al.
Published: (2019-02-01) -
Psychometric validation of the Dysmorphic Concern Questionnaire (DCQ) into Arabic
by: Feten Fekih-Romdhane, et al.
Published: (2024-02-01) -
The Role of the Cyclin Dependent Kinase Inhibitor p21<sup>cip1/waf1</sup> in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics
by: Samar Al Bitar, et al.
Published: (2019-09-01)